These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31582307)

  • 1. Skeletal effects of combined medical and surgical management of primary hyperparathyroidism.
    Orr LE; Zhou H; Zhu CY; Haigh PI; Adams AL; Yeh MW
    Surgery; 2020 Jan; 167(1):144-148. PubMed ID: 31582307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of bone mineral density improvement in patients undergoing parathyroidectomy for primary hyperparathyroidism.
    Sharma J; Itum DS; Moss L; Li C; Weber C
    World J Surg; 2014 Jun; 38(6):1268-73. PubMed ID: 24744114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal effects of combined bisphosphonates treatment and parathyroidectomy in osteoporotic patients with primary hyperparathyroidism.
    Choe HJ; Koo BK; Yi KH; Kong SH; Kim JH; Shin CS; Chai JW; Kim SW
    J Bone Miner Metab; 2022 Mar; 40(2):292-300. PubMed ID: 34761302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Parathyroid and bone. Skeletal derangement in patients with primary hyperparathyroidism].
    Takeuchi Y
    Clin Calcium; 2007 Dec; 17(12):1815-21. PubMed ID: 18057655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Observation Versus Parathyroidectomy on Bone Mineral Density and Fracture Risk Determined by FRAX Tool in Patients With Primary Hyperparathyroidism.
    Khan R; Martin J; Das G
    J Clin Densitom; 2021; 24(4):571-580. PubMed ID: 33390308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of skeletal health in patients with asymptomatic primary hyperparathyroidism.
    Lewiecki EM
    J Clin Densitom; 2010; 13(4):324-34. PubMed ID: 21029971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual site-specific bone mineral density gain in normocalcemic primary hyperparathyroidism.
    Koumakis E; Souberbielle JC; Payet J; Sarfati E; Borderie D; Kahan A; Cormier C
    Osteoporos Int; 2014 Jul; 25(7):1963-8. PubMed ID: 24676846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial.
    Ambrogini E; Cetani F; Cianferotti L; Vignali E; Banti C; Viccica G; Oppo A; Miccoli P; Berti P; Bilezikian JP; Pinchera A; Marcocci C
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3114-21. PubMed ID: 17535997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review and meta-analysis of the effect of bisphosphonate drug holidays on bone mineral density and osteoporotic fracture risk.
    Nayak S; Greenspan SL
    Osteoporos Int; 2019 Apr; 30(4):705-720. PubMed ID: 30623214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Relationship of Parathyroidectomy and Bisphosphonates With Fracture Risk in Primary Hyperparathyroidism: An Observational Study.
    Yeh MW; Zhou H; Adams AL; Ituarte PH; Li N; Liu IL; Haigh PI
    Ann Intern Med; 2016 Jun; 164(11):715-23. PubMed ID: 27043778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone mineral density changes after parathyroidectomy are dependent on biochemical profile.
    Lee D; Walker MD; Chen HY; Chabot JA; Lee JA; Kuo JH
    Surgery; 2019 Jan; 165(1):107-113. PubMed ID: 30327189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of bone mineral density and parathyroidectomy on fracture risk in primary hyperparathyroidism.
    VanderWalde LH; Liu IL; Haigh PI
    World J Surg; 2009 Mar; 33(3):406-11. PubMed ID: 18763015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of denosumab as compared with parathyroidectomy regarding calcium, renal, and bone involvement in osteoporotic patients with primary hyperparathyroidism.
    Miyaoka D; Imanishi Y; Kato E; Toi N; Nagata Y; Kurajoh M; Yamada S; Inaba M; Emoto M
    Endocrine; 2020 Sep; 69(3):642-649. PubMed ID: 32621048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in bone mineral density after surgical intervention for primary hyperparathyroidism.
    Dy BM; Grant CS; Wermers RA; Kearns AE; Huebner M; Harmsen WS; Thompson GB; Farley DR; Richards ML
    Surgery; 2012 Dec; 152(6):1051-8. PubMed ID: 23040710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marked improvement of psychiatric symptoms after parathyroidectomy in elderly primary hyperparathyroidism.
    Chiba Y; Satoh K; Ueda S; Kanazawa N; Tamura Y; Horiuchi T
    Endocr J; 2007 Jun; 54(3):379-83. PubMed ID: 17420608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of antiresorptive agents bisphosphonates and denosumab in mitigating hypercalcemia and bone loss in primary hyperparathyroidism: A systematic review and meta-analysis.
    Rajput S; Dutta A; Rajender S; Mithal A; Chattopadhyay N
    Front Endocrinol (Lausanne); 2023; 14():1098841. PubMed ID: 36817591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mineral density in primary care patients related to serum calcium concentrations: a longitudinal cohort study from Sweden.
    Dalemo S; Eggertsen R; Hjerpe P; Almqvist EG; Boström KB
    Scand J Prim Health Care; 2018 Jun; 36(2):198-206. PubMed ID: 29623754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary hyperparathyroidism: findings from the retrospective evaluation of cases over a 6-year period from a regional UK centre.
    Pappachan JM; Elnaggar MN; Sodi R; Jbeili K; Smith PR; Lahart IM
    Endocrine; 2018 Oct; 62(1):174-181. PubMed ID: 30019307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral Bisphosphonate use Reduces Cardiovascular Events in a Cohort of Danish Patients Referred for Bone Mineral Density.
    Rodríguez AJ; Ernst MT; Nybo M; Prieto-Alhambra D; Ebeling PR; Hermann AP; Abrahamsen B
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32717068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness of fracture prevention in postmenopausal women who receive aromatase inhibitors for early breast cancer.
    Ito K; Blinder VS; Elkin EB
    J Clin Oncol; 2012 May; 30(13):1468-75. PubMed ID: 22370313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.